المؤلفون: Masaki Akimoto, Hideo Ohtsubo, Tamami Yoshitama, Yoshiya Arishima, Tomomaro Izumihara, Takemasa Matsuda, Sanae Ohkura, Nobuhiko Sunahara, Nobutaka Eiraku

المصدر: Modern Rheumatology. 22:837-843

مصطلحات موضوعية: Male, Drug, medicine.medical_specialty, media_common.quotation_subject, Arthritis, Pharmacology, Severity of Illness Index, Gastroenterology, Arthritis, Rheumatoid, Rheumatology, Internal medicine, Severity of illness, medicine, Humans, Dosing, Aged, Retrospective Studies, media_common, Aged, 80 and over, Mizoribine, biology, business.industry, C-reactive protein, Middle Aged, medicine.disease, C-Reactive Protein, Treatment Outcome, Antirheumatic Agents, Rheumatoid arthritis, biology.protein, Female, Ribonucleosides, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ae175c0b95e532247eb85e316d8a3cf
https://doi.org/10.3109/s10165-012-0611-3